Basel, Switzerland; Roche reported (6/2004) that it “has the world’s largest manufacturing capacity for biopharmaceuticals,” with facilities in Basel, Switzerland; Penzberg, Germany; Nutley, NJ; within Genentech sites in Vacaville, CA, Porriño, Spain, and S. San Francisco; and at Chugai Pharmaceutical Co. Ltd. sites in Utsunomiya and Ukima, Japan; see also Genentech, of which Roche is the majority owner
